MRNS Marinus Pharmaceuticals Inc

USD 8.85 0.06 0.682594
Icon

Marinus Pharmaceuticals Inc (MRNS) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 8.85

+0.06 (+0.68)%

USD 0.48B

0.43M

USD 22.40(+153.11%)

N/A

Icon

MRNS

Marinus Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 8.85
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.48B

N/A

USD 8.85

Marinus Pharmaceuticals Inc (MRNS) Stock Forecast

Show ratings and price targets of :
USD 22.40
(+153.11%)

Based on the Marinus Pharmaceuticals Inc stock forecast from 4 analysts, the average analyst target price for Marinus Pharmaceuticals Inc is USD 22.40 over the next 12 months. Marinus Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Marinus Pharmaceuticals Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Marinus Pharmaceuticals Inc’s stock price was USD 8.85. Marinus Pharmaceuticals Inc’s stock price has changed by -2.10% over the past week, -11.50% over the past month and +41.37% over the last year.

No recent analyst target price found for Marinus Pharmaceuticals Inc
No recent average analyst rating found for Marinus Pharmaceuticals Inc

Company Overview Marinus Pharmaceuticals Inc

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY (ganaxolone), an oral suspension for the treatment of se...Read More

https://marinuspharma.com

5 Radnor Corporate Center, Radnor, PA, United States, 19087

165

December

USD

USA

Adjusted Closing Price for Marinus Pharmaceuticals Inc (MRNS)

Loading...

Unadjusted Closing Price for Marinus Pharmaceuticals Inc (MRNS)

Loading...

Share Trading Volume for Marinus Pharmaceuticals Inc Shares

Loading...

Compare Performance of Marinus Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for MRNS

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Marinus Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing MRNS

Symbol Name MRNS's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Marinus Pharmaceuticals Inc (MRNS) Stock

Based on ratings from 4 analysts Marinus Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 4 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on MRNS's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for MRNS is USD 22.40 over the next 12 months. The maximum analyst target price is USD 27 while the minimum anlayst target price is USD 9.

Unfortunately we do not have enough data on MRNS's stock to indicate if its overvalued.

The last closing price of MRNS's stock was USD 8.85.

The most recent market capitalization for MRNS is USD 0.48B.

Based on targets from 4 analysts, the average taret price for MRNS is projected at USD 22.40 over the next 12 months. This means that MRNS's stock price may go up by +153.11% over the next 12 months.

We can't find any ETFs which contains Marinus Pharmaceuticals Inc's stock.

As per our most recent records Marinus Pharmaceuticals Inc has 165 Employees.

Marinus Pharmaceuticals Inc's registered address is 5 Radnor Corporate Center, Radnor, PA, United States, 19087. You can get more information about it from Marinus Pharmaceuticals Inc's website at https://marinuspharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...